RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Maria Duarte to Adjuvants, Immunologic

This is a "connection" page, showing publications Maria Duarte has written about Adjuvants, Immunologic.
Connection Strength

0.278
  1. Ribeiro PAF, Dias DS, Lage DP, Mendon?a DVC, Vale DL, Ramos FF, Carvalho LM, Carvalho AMRS, Steiner BT, Roque MC, Oliveira-da-Silva JA, Oliveira JS, Tavares GSV, Martins VT, Ch?vez-Fumagalli MA, Roatt BM, Moreira RLF, Menezes-Souza D, Duarte MC, Oliveira MC, Machado-de-?vila RA, Teixeira AL, Coelho EAF. Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells. Parasitol Res. 2020 Aug; 119(8):2609-2622.
    View in: PubMed
    Score: 0.156
  2. Jesus MM, Lage DP, Vale DL, Freitas CS, Pimenta BL, Moreira GJL, Ramos FF, Pereira IAG, Bandeira RS, Ludolf F, Tavares GSV, Galdino AS, Duarte MC, Menezes-Souza D, Ch?vez-Fumagalli MA, Teixeira AL, Gon?alves DU, Roatt BM, Christodoulides M, Martins VT, Coelho EAF. Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis. Parasitol Res. 2023 Dec; 122(12):2917-2931.
    View in: PubMed
    Score: 0.049
  3. Oliveira-da-Silva JA, Machado AS, Ramos FF, Tavares GSV, Lage DP, Mendon?a DVC, Pereira IAG, Santos TTO, Martins VT, Carvalho LM, Freitas CS, Ludolf F, Reis TAR, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Roatt BM, Teixeira AL, Coelho EAF. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis. Cell Immunol. 2020 10; 356:104194.
    View in: PubMed
    Score: 0.039
  4. Ribeiro PAF, Dias DS, Lage DP, Costa LE, Martins VT, Tavares GSV, Mendon?a DVC, Lima MP, Oliveira JS, Steiner BT, Machado-de-?vila RA, Roatt BM, Ch?vez-Fumagalli MA, Menezes-Souza D, Duarte MC, Teixeira AL, Coelho EAF. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans. Cell Immunol. 2018 09; 331:67-77.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support